Boston Partners
THC icon

Boston Partners’s Tenet Healthcare THC Stock Holding History

Boston Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829M Buy
4,433,360
+598,399
+16% +$110M 0.74% 34
2026
Q1 		$724M Buy
3,834,961
+192,825
+5% +$40.6M 0.76% 31
2025
Q4 		$724M Buy
3,642,136
+494,581
+16% +$99.9M 0.75% 29
2025
Q3 		$639M Buy
3,147,555
+880,413
+39% +$156M 0.66% 42
2025
Q2 		$399M Buy
2,267,142
+1,104,500
+95% +$166M 0.44% 69
2025
Q1 		$156M Buy
1,162,642
+1,016,010
+693% +$134M 0.19% 176
2024
Q4 		$18.5M Sell
146,632
-7,692
-5% -$1.14M 0.02% 335
2024
Q3 		$25.6M Sell
154,324
-219
-0.1% -$33.1K 0.03% 302
2024
Q2 		$20.6M Buy
154,543
+35,195
+29% +$4.24M 0.03% 325
2024
Q1 		$12.5M Buy
119,348
+83,231
+230% +$7.48M 0.01% 378
2023
Q4 		$2.73M Buy
36,117
+30,356
+527% +$1.92M ﹤0.01% 473
2023
Q3 		$380K Sell
5,761
-32
-0.6% -$2.39K ﹤0.01% 671
2023
Q2 		$471K Sell
5,793
-2,170
-27% -$154K ﹤0.01% 630
2023
Q1 		$473K Sell
7,963
-2,981
-27% -$166K ﹤0.01% 602
2022
Q4 		$534K Buy
10,944
+3,952
+57% +$183K ﹤0.01% 589
2022
Q3 		$361K Buy
+6,992
New +$415K ﹤0.01% 634

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Boston Partners's THC Position: Q2 2026 in Review

Boston Partners increased its Tenet Healthcare (THC) stake by 16% in Q2 2026, buying an estimated $110M and bringing the position to 4,433,360 shares worth $829M. The position accounts for 0.74% of the portfolio, ranked #34.

Boston Partners first reported a position in THC in Q3 2022 and has held it in 16 quarters since. 677 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Boston Partners held 4,433,360 shares of Tenet Healthcare worth $829M as of Q2 2026.
  • Boston Partners bought 598,399 Tenet Healthcare shares in Q2 2026, an estimated $110M.
  • Tenet Healthcare made up 0.74% of Boston Partners's portfolio in Q2 2026, its #34 holding.
  • Boston Partners first reported a position in Tenet Healthcare in Q3 2022 and has held it in 16 quarters since.
  • 677 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.